(Q38553245)

English

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis

scientific article published on January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

0 references

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis (English)

1 reference

Europe PubMed Central

4 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

autoimmune disease

1 reference

based on heuristic

inferred from title

author name string

D G Wahl

1

1 reference

Europe PubMed Central

4 September 2017

F Guillemin

2

1 reference

Europe PubMed Central

4 September 2017

E de Maistre

3

1 reference

Europe PubMed Central

4 September 2017

C Perret-Guillaume

4

1 reference

Europe PubMed Central

4 September 2017

T Lecompte

5

1 reference

Europe PubMed Central

4 September 2017

G Thibaut

6

1 reference

Europe PubMed Central

4 September 2017

publication date

1 January 1998

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

7

1 reference

Europe PubMed Central

4 September 2017

1

1 reference

Europe PubMed Central

4 September 2017

15-22

1 reference

Europe PubMed Central

4 September 2017

The antiphospholipid syndrome: ten years on.

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Assays for detection of antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Quantitative methods in the review of epidemiologic literature

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a "mission impossible'?

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Thrombosis in the Antiphospholipid-Antibody Syndrome

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Clinical recommendations using levels of evidence for antithrombotic agents

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1191%2F096120398678919688

21 January 2018

Identifiers

10.1191/096120398678919688

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38553245&oldid=1766841784"